A Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents

NCT ID: NCT05722652

Last Updated: 2025-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

667 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-27

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to refine and test CONFIDENCE, a multi-component clinic-based intervention in pediatric or family practice clinical settings. Using a randomized control trial design, the investigators will assess preliminary effectiveness of the intervention to increase COVID-19 vaccine intention among parents of under-vaccinated children ages 5 to 17.

Participating clinics will receive a brief intervention consisting of: (1) webinar training focused on communication with vaccine-hesitant parents, (2) parent-facing educational materials about COVID-19 vaccination, (3) support to create a personalized, poster campaign featuring providers. Clinics in the control condition will receive the intervention approximately 12 months after the clinics in the intervention condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Vaccination

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The investigators will be using a cluster, randomized control trial design, in which clinics are assigned to either the intervention or control group. Clinics in the control group or "waitlist" condition, will receive the intervention approximately 12 months later.
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
Clinics will know if they are assigned to the intervention or control condition. However, individual participants (parents of children ages 5 to 17) will not know if their clinic is in the intervention or control condition.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Condition

Group Type EXPERIMENTAL

CONFIDENCE

Intervention Type BEHAVIORAL

This clinic-based, multicomponent intervention consists of 3 parts:

1. Webinar training for clinicians and clinic staff about how to communicate with vaccine-hesitant parents
2. Parent-facing educational materials about COVID-19 vaccination
3. Support in creating a personalized poster campaign featuring providers and clinic staff sharing personal stories about COVID-19 vaccination

Waitlist Condition

Clinics in this condition will receive the intervention approximately 12 months after the intervention condition.

Group Type ACTIVE_COMPARATOR

CONFIDENCE

Intervention Type BEHAVIORAL

This clinic-based, multicomponent intervention consists of 3 parts:

1. Webinar training for clinicians and clinic staff about how to communicate with vaccine-hesitant parents
2. Parent-facing educational materials about COVID-19 vaccination
3. Support in creating a personalized poster campaign featuring providers and clinic staff sharing personal stories about COVID-19 vaccination

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CONFIDENCE

This clinic-based, multicomponent intervention consists of 3 parts:

1. Webinar training for clinicians and clinic staff about how to communicate with vaccine-hesitant parents
2. Parent-facing educational materials about COVID-19 vaccination
3. Support in creating a personalized poster campaign featuring providers and clinic staff sharing personal stories about COVID-19 vaccination

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric or family practice clinic that serves pediatric population (ages 5 to 17)
* Affiliated with UMass Memorial Health Care and/or Baystate Health
* Serve a patient population that is at least 30% racial/ethnic minority group members.



* Parent/guardian (referred to as parents in this proposal) of child between ages 5 and 17
* Able to read and write in English, Spanish, Portuguese or Vietnamese, which are the predominant languages in the target communities
* Parent of patient at participating clinical site/child received non-urgent care visit during study period
* Child not up-to-date for COVID-19 per current CDC guidelines at the time of enrollment.

Exclusion Criteria

°Parent under age of 18
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role collaborator

Baystate Health

OTHER

Sponsor Role collaborator

University of Massachusetts, Worcester

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephenie Lemon

Professor and Chief of the Division of Preventive and Behavioral Medicine, Department of Population and Quantitative Health Sciences

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephenie C Lemon, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Massachusetts Chan Medical School

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UMass Chan Medical School

Worcester, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Ryan GW, Goulding M, Borg A, Minkah P, Beeler A, Rosal MC, Lemon SC. Development and Beta-Testing of the CONFIDENCE Intervention to Increase Pediatric COVID-19 Vaccination. J Pediatr Health Care. 2023 May-Jun;37(3):244-252. doi: 10.1016/j.pedhc.2022.11.002. Epub 2022 Nov 17.

Reference Type BACKGROUND
PMID: 36470798 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00000728

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Booster Readiness Survey
NCT05529030 COMPLETED NA
COVID-19 Booster Incentives
NCT05648773 COMPLETED NA
COVID-19 and Mental Health
NCT04407195 COMPLETED